ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.00%
Bitcoin
66,926.77
-0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. European Biotech Acquisition Corporation (EBACU)

  7. European Biotech Acquisition Corporation (EBACU) News

EBACU

European Biotech Acquisi... (EBACU)

European Biotech Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EBACU
DateTimeSourceHeadlineSymbolCompany
03/13/20233:10PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/28/20233:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/28/20235:12AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/21/20234:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/14/20233:14PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/14/202310:33AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/13/20233:05PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/06/20233:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/03/20234:11PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
01/30/20237:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
12/14/20228:17AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
11/14/202211:43AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
10/17/20228:52AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
08/15/20224:39PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
05/16/20221:30PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
03/31/20224:05PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
02/14/20225:25AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
01/27/20223:36PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
11/23/20215:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
11/23/20215:04AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
11/15/20214:02PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
08/18/20213:41PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
06/22/20214:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
06/04/20213:40PMBusiness WireEuropean Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly ReportNASDAQ:EBACUEuropean Biotech Acquisition Corporation
06/04/20213:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
05/17/20213:08PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
05/14/202110:00AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
05/07/20214:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
05/04/20214:19PMBusiness WireEuropean Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares & Warrants Commencing May 6,...NASDAQ:EBACUEuropean Biotech Acquisition Corporation
04/02/20213:02PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EBACUEuropean Biotech Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:EBACU

Your Recent History

NYSE
GR
Goodrich
COIN
RALLYUST
Rally Coin
BTHB
SNXKRW
Synthetix Network Token
KOSPI
001720
Shinyoung Securities
LSE
ZV16
Rep Serbia 30 A
BOV
D2KS34
Dicks Sporting Goods
LSE
BGY
British Energy
AMEX
CVSL
CVSL Inc.
NYSE
GGT-E
Gabelli Multimedia
USOTC
VRSCF
Nickelex Resource (QB)
BIT
UC1MWV
Unicredit Bank
BMF
BRLUSD16
BRLUSD16
ASX
BHPLOF
ASX
CR1N
Constellation Resources
ASX
ROL
Robust Resources
BIT
GHYEH
ETF
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved